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OBJECTIVES: The effectiveness of fecal immunochemical test (FIT) screening for colorectal cancer depends on timely
colonoscopy follow-up of positive tests, although limited data exist regarding effective system-level
strategies for improving follow-up rates.
METHODS: Using amixed-methods design (qualitative and quantitative), we first identified system-level strategies
that were implemented for improving timely follow-up after a positive FIT test in a large community-
based setting between 2006 and 2016. We then evaluated changes in time to colonoscopy among
FIT-positive patients across 3 periods during the study interval, controlling for screening participant
age, sex, race/ethnicity, comorbidity, FIT date, and previous screening history.
RESULTS: Implemented strategies over the study period included setting a goal of colonoscopy follow-upwithin 30
days of a positive FIT, tracking FIT-positive patients, early telephone contact to directly schedule follow-
up colonoscopies, assigning the responsibility for follow-up tracking and scheduling to gastroenterology
departments (vs primary care), and increasing colonoscopy capacity. Among160,051patientswhohad
a positive FIT between 2006 and 2016, 126,420 (79%) had a follow-up colonoscopy within 180 days,
including 67% in 2006–2008, 79% in 2009–2012, and 83% in 2013–2016 (P < 0.001). Follow-
upwithin 180 days in 2016 variedmoderately across service areas, between 72% (95%CI 70–75) and
88% (95%CI86–91), but therewere no obvious differences in the pattern of strategies implemented in
higher- vs lower-performing service areas.
CONCLUSIONS: The implementation of system-level strategies coincided with substantial improvements in timely
colonoscopy follow-up after a positive FIT. Intervention studies are needed to identify themost effective
strategies for promoting timely follow-up.
SUPPLEMENTARY MATERIAL accompanies this paper at http://links.lww.com/CTG/A13
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INTRODUCTION
Stool testing for occult blood to screen for colorectal cancer
(CRC) has been shown to reduce CRC incidence and mortality
(1). The fecal immunochemical test (FIT) has largely replaced
guaiac-based fecal screening because of improved sensitivity of
FIT screening for CRC and advanced adenomas, speciﬁcity for
human hemoglobin, and acceptance by screening participants
(2). Although colonoscopy remains the dominant CRC screening
test in theUnited States (3), FITs are increasingly recognized as an
important component of CRC screening programs, given that
they are noninvasive, can be mailed through outreach and com-
pleted at home, and can increase overall screening rates (4,5).
FIT-based screening is a 2-step process that requires timely
colonoscopy follow-up after a positive test. European and Ca-
nadian guidelines recommend follow-up within 30 and 60 days,
respectively (6,7), and delays of longer than 6 months are asso-
ciated with an increased risk of any CRC and advanced CRC (8).
Although rates of colonoscopy follow-up in landmark random-
ized trials were 80% to 90% (9),multiple screening programs have
reported that as few as 50% of test-positive screening participants
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get appropriate follow-up (10–13). Follow-up is challenging in
that it requires referral from primary care to gastroenterology,
evaluation of patient suitability, explaining the need for an in-
vasive diagnostic test, following complex bowel preparation
instructions, and undergoing the invasive procedure itself (14). In
addition, participantsmaymisunderstand recommendations, fail
to perceive themselves as at increased cancer risk, or be reluctant
to undergo an invasive procedure (15). Organized screening
programs in Europe usually mail results to both referring
physicians and participants, sometimes augmented by person-
alized telephone calls (16) or default follow-up appointments
(17). They typically have higher rates of colonoscopy follow-up
than those seen in the United States. A recent systematic review
found moderate evidence to support patient navigators and
provider reminder systems to improve follow-up, but scant evi-
dence about useful system-level strategies (18). Some studies have
suggested that strategies such as automated referral to gastroen-
terology, electronic registries to track patients, and quality im-
provement eﬀorts can provide modest improvements, but these
studies had signiﬁcant potential biases (19–21). Given that par-
ticipant-, provider-, and system-level factors can all contribute to
lack of follow-up (22), sustained strategies at multiple levels may
be beneﬁcial.
In 2006, Kaiser Permanente Northern California (KPNC)
shifted from opportunistic CRC screening (primarily sigmoid-
oscopy) to an organized annual FIT-based mailed outreach
screening program for all screening eligible members com-
plemented by opportunistic screening colonoscopy (by request).
This led to substantial improvements in the percentage of eligible
adults up to date with screening, reaching.80% (23–25). In the
current study, we sought to identify and describe the stepwise
implementation of numerous system-level strategies to improve
timely colonoscopy follow-up of positive FITs between 2006 and
2016. We then evaluated changes in time to colonoscopy over 3
periods across the 10-year study interval. Finally, for 2016, we
compared colonoscopy completion rates and implementation of
strategies between service areas.
METHODS
Setting
This mixed-methods study (i.e., using both qualitative and
quantitative analyses) was conductedwithinKPNC, an integrated
health plan with approximately 4.1 million current members.
KPNC has a diverse membership that resembles the US adult
census population in California, except at extremes of income
(26). The studywas approved by the Institutional ReviewBoard of
KPNC, and a waiver for informed consent was obtained. KPNC is
served by 24 gastroenterology departments in 15 service areas.
Service areas are responsible for KPNC members living in their
geographic area; each has its own leadership and considerable
autonomy to actualize processes like FIT-positive follow-up.
KPNCmembers aged 50 to 75 years weremailed FIT kits annually
if they were identiﬁed as due for screening (i.e., did not have
a colonoscopy within 10 years or have a diagnosis conferring
increased risk of CRC). A preletter preceded the mailed FIT kits
by 1 week, followed by an automated telephone call at 5 weeks
postmailing and a reminder letter at 7 weeks after. Eligible
members then received personalized messages and telephone
reminders as needed after FIT kits were mailed. Electronic
reminders in the electronic health record also ﬂagged patients due
for screening and providers distributed additional FIT kits during
primary care visits. Members mailed their FITs to a regional
laboratory, where they were reported as positive if they had.20mg
of hemoglobin per gram of buﬀer. Colonoscopy was the only rec-
ommended follow-up for a positive FIT result.
Characterization of strategies implemented across service areas
Strategies to promote FIT-positive follow-up across service areas
between 2006 and 2016 were identiﬁed and described through
systematic interviews with leaders of the KPNC CRC screening
program and gastroenterology departments, followed by site
visits to 4 gastroenterology departments (split between service
areas with follow-up rates in the highest and lowest quartiles at
180 days) and 1 primary care department using semistructured
interviews. During site visits, staﬀ at all levels, from department
chiefs to nurse coordinators, medical assistants, and schedulers
were interviewed. We used that information to create a concep-
tual model of FIT-positive follow-up and the various strategies
implemented to improve follow-up rates over the study interval.
We then identiﬁed which service areas implemented which
strategies using an electronic, 22-item questionnaire distributed
by email to the gastroenterology leadership staﬀ for all 15 KPNC
service areas (see Supplement, Supplementary Digital Content 1,
http://links.lww.com/CTG/A13); 1 questionnaire was completed
by the department chief in 13 of 15 service areas, and in 1 service
area, both the gastroenterology department chief and a de-
partment head responded separately because of diﬀerences in the
organization between their departments. One service area did not
complete the questionnaire. The questionnaire was distributed in
fall 2017 and primarily asked leadership about FIT-positive
follow-up at the time of the questionnaire, such as whether the
gastroenterology department awaited electronic referrals vs di-
rectly accessed test results, had a dedicated person assigned to
track FIT-positive participants, and had implementedmethods to
contact FIT-positive participants and close cases when no colo-
noscopy was performed.
Cohort of screening participants with a positive FIT
To evaluate time to colonoscopy after a positive FIT, we created
a cohort of all KPNC members aged 50–76 years on their FIT
result date who had a positive FIT between January 1, 2006, and
December 31, 2016. A small number of participants (;4%) had
more than 1 positive test during follow-up, and to avoid double
counting, only their ﬁrst positive test was included.
Participant measurements
Participant characteristics such as date of birth, sex, and race/
ethnicity were obtained from electronic health records in the year
of the FIT result. Charlson comorbidity scores were computed
with a standard algorithm using ICD-9 (International Classiﬁ-
cation of Diseases, 9th revision) codes from care episodes in the
calendar year before the FIT (27). Previous colonoscopy or sig-
moidoscopy was yes/no variables for procedures before the
index-positive FIT. Each participant was assigned to a KPNC
service area, either bywhere they had their colonoscopy or, if they
did not have a colonoscopy, the service area of their primary care
provider.
Analyses
Because discrete dates for strategy implementation were not
available (and strategies were often implemented over months
across diﬀerent centers), we stratiﬁed participants into 3 time
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intervals based on the date of FIT: 2006–2008, 2009–2012, and
2013–2016. These dates coincided with concerted eﬀorts to im-
prove follow-up initiated in 2009–2010 and 2013. We used Cox
regression to estimate cumulative incidence curves for each of the
3 time intervals (showing the proportion who received colono-
scopy (in days) after a positive FIT), standardized to the overall
average covariate proﬁle. The covariates included participant age
at FIT result date, sex, race/ethnicity, Charlson comorbidity score,
previous colonoscopy, previous sigmoidoscopy, and the season of
the year. Nine hundred nineteen participants (0.6%) had missing
data and were excluded from the models. In our ﬁrst model,
comparisons between periods focused on the cumulative pro-
portion with a colonoscopy within 180 days because follow-up
colonoscopy after 6 months is associated with worse clinical
outcomes (8). In 2 sensitivity analyses, we evaluated the time
intervals 2006–2009, 2010–2013, and 2014–2016 and repeated
the period analysis using a robust sandwich estimator to calculate
conﬁdence intervals. In our second model, we calculated the
cumulative proportion of FIT-positive participants in 2016 with
a colonoscopy at 30 and 180 days for each of the 15 KPNC service
areas.We then ranked service areas by colonoscopy completion at
30 and 180 days and qualitatively compared the patterns of
strategy implementation in higher- vs lower-performing service
areas. For quantitative analyses, P , 0.05 was considered statis-
tically signiﬁcant, and all analyses were performed using STATA
version 14.2 (StataCorp, College Station, TX).
RESULTS
Description of system-level strategies implemented to promote
FIT-positive follow-up (all service areas)
Successive changes to FIT-positive follow-up between 2006
and 2016 (Table 1) led to the current system noted in Figure 1.
System-wide strategies already in existence in 2006 included an
integrated electronic health record shared by primary care and
gastroenterologists, a focus on preventive health, central man-
agement of colonoscopy scheduling in each gastroenterology
department, and support staﬀ for managing patient panels. Be-
tween 2006 and 2008, in response to large increases in the number
of screening participants requiring diagnostic and surveillance
colonoscopies following implementation of organized FIT-based
screening, several system-level strategies were implemented
across all service areas (Table 1):
1. Hiring additional gastroenterology personnel to expand
endoscopy capacity.
2. Institution of a policy that participants not responding to
telephone calls or secure messages were sent a certiﬁed letter
informing them of their increased risk of CRC after a positive
FIT and their need for follow-up.
Between 2009 and 2012, additional system-level strategies
implemented included:
1. Standardization of outreach by gastroenterology department
schedulers whereby all FIT-positive participants with a referral
received a minimum of 3 repeat telephone attempts at varying
times of day and 1 or more personalized secure electronic
messages over 10–21 days.
2. A dedicated staﬀmember in each service area, typically a nurse
practitioner (NP) or equivalent, was assigned responsibility
for ensuring that standard processes were being followed.
3. Established a goal that $80% of FIT-positive participants,
accessible by telephone and not requiring medical evaluation,
would complete their diagnostic colonoscopy within 30 days
of testing positive.
4. A proportion of each medical center’s overall budget was
withheld at the beginning of each year and only dispensed if
targets for overall colonoscopy access and timely follow-up
were met. Physician salaries were not subject to change based
on these targets, but the policy encouraged departments to
maintain adequate colonoscopy capacity and scheduling
ﬂexibility to allow scheduling within about 2 weeks of
telephone contact after a positive FIT.
Table 1. Strategies implemented between 2006 and 2016 to
increase timely colonoscopy follow-up of positive fecal
immunochemical tests within KPNC
Period Strategies
Existing facilitators
within KPNC (39)
Integrated electronic health record across all sites
Focus on preventive health
Support staff for panel management
2006–2008 Hired additional gastroenterologists (increased
from 60 to.100) and nurses; built additional
endoscopy suites
Increased number of colonoscopies from25,000 to
nearly 100,000 per year
Adopted a policy that a certified letter be sent if FIT-
positive participants could not be reached to
schedule a colonoscopy
2009–2012 Health plan designated follow-up colonoscopy
a screening examination to avoid copayments
Established a goal of $80% of FIT-positive
participants complete follow-up colonoscopy
within 30 d of a positive test; those unreachable by
telephone or requiring medical evaluation were not
included in the denominator
Adopted a policy whereby medical centers had
a portion of their annual budget retained and only
released if they met colonoscopy access targets
Created patient and condition tracking system,
a central registry to flag FIT-positive patients without
a colonoscopy at 30, 60, and 90 d after a positive
FIT. Lists of patients with inadequate action were
provided to each service area
2013–2016 Gastroenterology departments directly provided
FIT-positive participant lists and assumed direct
responsibility for follow-up, even if no referral was
placed
Identified a designated person responsible for FIT-
positive participant tracking at each
gastroenterology facility
Implemented standardized outreach by
navigators: minimum 3 calls, standard letter
quoting cancer risk; if no contact, participant
flagged as unable to contact and primary care
provider notified
FIT, fecal immunochemical test; KPNC, Kaiser PermanenteNorthernCalifornia.
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Between 2013 and 2016, several gastroenterology departments
began directly contacting participants by accessing daily lists of
FIT-positive participants. FIT results from the central laboratory
continued to be sent electronically to the patient’s primary care
provider. Primary care providers had the option to contact their
patients directly to inform them of their FIT result and to place an
electronic referral with their local gastroenterology department.
However, an increasing proportion of participants were ﬁrst
contacted by a medical assistant or NP from the gastroenterology
department, who explained the FIT result and directly booked the
colonoscopy. Participants with concerns about the appropriate-
ness of colonoscopy (e.g., severe comorbidities or participant
refusal) were ﬂagged for review by a gastroenterologist.
Overall cohort characteristics
Among 160,051 screening participants who had a positive FIT
between 2006 and 2016, themean age of participantswas 62 years,
75,594 (47%) were women, and 90,545 (57%) were non-Hispanic
white, 26,547 (17%) Asian, 20,388 (13%) Hispanic, 11,101 (7%)
African American, and 11,470 (7%) other. There were no sub-
stantive diﬀerences in participant characteristics across the 3
study time intervals (Table 2).
Changes in time to colonoscopy follow-up after a positive FIT (all
service areas)
Time to colonoscopy after a positive FIT signiﬁcantly improved
over the 10-year study period (Figure 2), concordant with the
serial implementation of the described strategies (Table 1). After
adjusting for participant characteristics, the proportion of par-
ticipants who completed colonoscopy within 30 days after
a positive FIT more than doubled between 2006–2008 and
2009–2012, from 9% (95% CI 9%–10%) to 23% (95% CI
23%–24%), and further to 34% in 2013–2016 (95% CI 34%–35%,
P , 0.001). The proportion who completed colonoscopy within
180 days increased signiﬁcantly from 67% in 2006–2008 (95% CI
66%–68%) to 79% in 2009–2012 (95% CI 78%–80%) and 83% in
2013–2016 (95%CI 83%–84%, P, 0.001). In sensitivity analyses,
we used the time intervals 2006–2009, 2010–2013, and
2014–2016 and repeated the analyses accounting for possible
clustering by service areas, but in both cases obtained very similar
results (not shown).
Strategies which varied across service areas in 2016
Although the model described in Figure 1 had been implemented
in most service areas by the end of the study period, variability
remained (Table 3). For example, there was variation in the job
title of those contacting participants (i.e., medical assistant or
medical assistant team, NP, and physician assistant). In 8 of 14
responding service areas, a licensed provider (i.e., nurse or phy-
sician) attempted to contact participants before removing their
name from the active list and notifying their primary care pro-
vider that no colonoscopy could be scheduled. In addition, only 3
service areas reported regular reviews of FIT-positive follow-up
performancemetrics, and only 4 reported consistent colonoscopy
availability within 2weeks of contacting participants. To examine
whether service areas with higher colonoscopy completion rates
at 30 and 180 days could be diﬀerentiated by the speciﬁc strategies
implemented, we ranked service areas by their colonoscopy
follow-up performance (Table 3). This analysis involved 21,291
participants who had a positive FIT in 2016. After adjusting for
diﬀerences in participant characteristics across the 15 service
areas, follow-up colonoscopy within 30 days varied between 10%
(95% CI 9%–12%) to 59% (95% CI 56%–61%) (Table 3), and
follow-up within 180 days varied between 72% (95% CI
70%–75%) and 88% (95% CI 86%–91%), with all but 1 service
area having.80% completion within 180 days. However, we did
not ﬁnd any obvious patterns suggesting that higher performing
service areas had implemented speciﬁc strategies or a greater
number of strategies. For instance, two high-performing service
areas (rankedﬁrst andﬁfth inTable 3) did not designate a person for
tracking FIT-positive participants, neither routinely evaluated
follow-up metrics, and only 1 directly accessed FIT-positive results.
Figure 1. Organization of follow-up of participants with positive FITs. Color coding reflects the period when elements were implemented. FIT, fecal
immunochemical test; MA, medical assistant; NP, nurse practitioner; PA, physician assistant; PROMPT, patient reminder, outreach management, patient
tracking system.
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DISCUSSION
Over 10 years, KPNC implemented several system-level strategies
to improve FIT-positive follow-up rates, including establishing
a 30-day goal for colonoscopy follow-up of positive FIT results,
increasing colonoscopy capacity, developing a registry add-on
to the electronic health record, and initiating early telephone
contact with all test-positive participants. The system-wide
implementation of these strategies coincided with substantial
and signiﬁcant improvements in timely colonoscopy follow-up
between 2006 and 2016, with 84% of test-positive participants
receiving a colonoscopy within 180 days of their FIT-positive
result in 2016. However, for 2016, we did not ﬁnd any obvious
patterns suggesting that higher performing service areas had
implemented speciﬁc strategies or a greater number of strategies.
Follow-up colonoscopy rates after positive stool tests vary
widely by setting, but little is known about what diﬀerentiates
programs with higher vs lower follow-up rates. Several US pub-
lications have reported 50%–60% follow-up rates after 6 months
or 1 year, with gaps in care at multiple levels, including fecal
testing of participants for whom colonoscopy is not appropriate
because of age and comorbidities; primary care providers re-
peating fecal testing or failing to refer to gastroenterology
departments; participants failing to present for colonoscopy; and
system failures to track participants and adequately document
reasons for not coordinating follow-up (10,12,22,28). A recent
study reported marked diﬀerences in time to colonoscopy after
a positive FIT between 4 health systems, including KPNC (11).
The authors speculated that better rates of follow-up atKPNCvs 2
other integrated health systems (81% colonoscopy completion at
6 months vs 74% and 63%, respectively) might have been due to
system-level factors, such as goal setting, regular performance
monitoring, and control over colonoscopy capacity. KPNC chose
a 30-day follow-up goal to minimize participant anxiety (con-
sistent with European guidelines (6)) and to promote eﬃcient
processes of care. Recent research suggests that follow-up within
180 days after a positive FIT is not associated with adverse CRC
outcomes (8), although no consensus exists on the appropriate
follow-up interval. The fourth health system, a county-wide
safety-net system, had only 50% follow-up at 6 months; the study
authors speculated that the absence of a patient registry,
Table 2. Patient characteristics stratified by period
Patient characteristic
Period
Overall (N 5 160,051)2006–2008 (n5 20,693) 2009–2012 (n5 62,736) 2013–2016 (n5 76,622)
Sex
Male 9,606 (46%) 29,627 (47%) 36,368 (47%) 75,601 (47%)
Female 11,087 (54%) 33,109 (53%) 40,254 (53%) 84,450 (53%)
Age, yr
50–59 7,824 (38%) 26,048 (42%) 33,896 (44%) 67,768 (42%)
60–69 8,224 (40%) 25,089 (40%) 30,503 (40%) 63,816 (40%)
70–75 4,645 (22%) 11,599 (18%) 12,223 (16%) 28,467 (18%)
Race/ethnicity
Non-Latino white 12,252 (59%) 36,035 (57%) 42,258 (55%) 90,545 (57%)
Black 1,205 (6%) 4,378 (7%) 5,418 (7%) 11,101 (7%)
Asian 3,170 (15%) 10,003 (16%) 13,374 (17%) 26,547 (17%)
Hispanic 2,262 (11%) 7,525 (12%) 10,601 (14%) 20,388 (13%)
Other 1,704 (8%) 4,795 (8%) 4,971 (6%) 11,470 (7%)
Participant obese (BMI$30 kg/m2)a 7,851 (38%) 25,105 (40%) 30,433 (40%) 63,389 (40%)
Season test completed
Winter 4,429 (21%) 16,425 (26%) 20,349 (27%) 41,203 (26%)
Spring 5,416 (26%) 20,340 (32%) 23,977 (31%) 49,733 (31%)
Summer 6,065 (29%) 16,287 (26%) 21,836 (29%) 44,188 (29%)
Fall 4,783 (23%) 9,684 (15%) 10,460 (14%) 24,927 (16%)
Previous sigmoidoscopy 7,598 (37%) 23,240 (37%) 23,071 (30%) 53,909 (34%)
Previous colonoscopy 1,342 (6%) 3,356 (5%) 4,421 (6%) 9,119 (6%)
Charlson comorbidity score
0 12,853 (62%) 38,229 (61%) 47,205 (62%) 98,287 (61%)
1 or 2 6,033 (29%) 17,411 (28%) 19,860 (26%) 43,304 (27%)
$3 1,807 (9%) 7,096 (11%) 9,557 (12%) 18,460 (12%)
BMI, body mass index.
aBody mass index missing for 3,508 patients (2%) of the cohort.
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inadequate colonoscopy capacity, and patient-level diﬀerences
may have been contributing factors. Rates of colonoscopy follow-
up within 6 months of .80% have been reported by several in-
ternational organized screening programs, including a regional
program in Italy with follow-up rates over 90% (29). These pro-
grams typically informbothparticipants andproviders of FIT results
by letter and/or telephone and manage colonoscopy appointments
centrally, allowing for direct booking of colonoscopies when
reporting test results (17,29,30). Early contact with all FIT-positive
participants, as was done at KPNC, may partly explain the higher
follow-up rates (31). Follow-up rates may also be lower in health
systems with high rates of opportunistic screening colonoscopy, like
many US programs; FIT in these settings may be more likely to be
completed by participants reluctant to undergo colonoscopy.
Several of the strategies implemented within KPNC between
2006 and 2016 have been reported to be eﬀective in other settings.
A systematic review foundmoderate evidence supporting patient
navigators, usually nurses, and reminders to primary care pro-
viders to complete colonoscopy referrals for FIT-positive par-
ticipants (18). In the present study, most telephone contacts with
FIT-positive participants were made by medical assistants or
schedulers, typically using standardized scripts to educate and
motivate patients, similar to randomized trials with nurse
navigators (32,33) In 2 service areas, primary care departments
tracked FIT-positive participants and reminded physicians to
contact their patients and complete referrals; in the other service
areas, staﬀ in gastroenterology departments directly contacted
participants to convey results and make electronic referrals,
eliminating the need for primary care provider reminders. Two
previous studies reported that automatic electronic referral to
gastroenterology increased follow-up (34,35). Research from the
Veterans Aﬀairs health system found that direct referral to gas-
troenterology and adequate colonoscopy capacitywere associated
with shorter times to colonoscopy (20,36). Finally, another US
health system achieved follow-up rates of over 80%with a registry
and manual nurse audit (37).
Strengths of our study include a systematic qualitative and
quantitative evaluation of practice variation within a large, multicen-
ter, diverse community-based setting; evaluation of both system-wide
and local strategies to improve follow-up; comprehensive follow-upof
many FIT-positive participants; linkage of practice variation with
patient outcomes; and the ability to track the same outcome while
adjusting for participant characteristics over the study interval.
Limitations include the retrospective observational design,
which decreased precision regarding the timing of each strategy’s
implementation, and the overlap of strategy implementation
Figure 2. Time to colonoscopy after a positive fecal immunochemical test among all screening participants from Kaiser Permanente Northern California,
stratified by period. Curves created using a Cox proportional hazard model of the time to colonoscopy, adjusting for patient characteristics.
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Table 3. Implementation of system-level strategies for colonoscopy follow-up of FIT-positive participants in 15 Kaiser Permanente Northern California service areas, ranked by
colonoscopy rate by 30 days
Service
area
rank
Colonoscopy completed Positive
FIT results
in 2016 (n)
Changes in
last 2 yr?b
Changes
plannedc
Gastroenterology department Longest wait for
follow-up (wk)e
Primary
method for
patient contact
Patient contacted
before close outf
Primary care
provider
notified if
closed out
Follow-up
metrics
reviewedg
By 30
da (%)
By 180
d (%)
Mean
time (d)
Direct access to
FIT resultsd
Designated person
responsible for
follow-up
1 59 88 80 1,779 Yes Yes Yes No 6 Telephone Yes Yes No
2 53 86 84 944 No No Yes RN and MA 6 Telephone Yes Yes No
3 48 85 94 776 No No Yes NP 4 Telephone No No No
4 47 88 76 766 No No Yes MA 2 Telephone Yes Yes Yes
5 46 86 87 2,403 No No Await referral No 3 Telephone No Yes No
6 34 84 104 499 Yes No Yes MA 1 Telephone Yes Yes No
7 30 85 96 1,288 Yes No Yes NP 1 Telephone Yes Yes No
8 28 86 95 779 No Yes Await referral NP 1 Telephone No Yes Uncertain
9 28 81 108 1,684 No No Yes MA team and MD 7 Telephone No Yes No
10 26 84 102 1,079 No No Yes NP 1 Telephone No Yes No
11 26 81 110 1,657 Yes Yes Yes RN and MA 2 Telephone Yes Yes No
12 23 81 119 1,779 No Yes Await referral MD and NP 8 Telephone No Yes Yes
13h 17 83 121 882
14 13 81 123 3,346 No No Await referral NP 6 Telephone No Yes Yes
15ai 10 72 155 1,630 No No Yes NP 8 Telephone Yes Yes No
15bi 10 72 155 1,630 Yes Yes Yes PA 4 Secure
message
Yes Yes No
Colonoscopy completion rates for all FIT-positive participants in 2016 calculated using the Cox proportional hazardmodel of the time to colonoscopy, adjusting for participant characteristics. Less frequent answers are highlighted in
gray.
FIT, fecal immunochemical test; MA, medical assistant; NP, nurse practitioner; PA, physician assistant; PCP, primary care provider; RN, registered nurse.
aKaiser Permanente Northern California regional target was to follow-up $80% of FIT-positive patients, accessible by telephone and not requiring medical evaluation, within 30 days.
bExamples of recent strategies implemented included the gastroenterology department taking responsibility for FIT-positive patient follow-up, accessing results directly, and designating a responsible person for follow-up.
cExamples of strategies to be implemented included hiring additional gastroenterologists and ongoing quality improvement efforts.
dAwait referral refers to waiting for a colonoscopy referral from the primary care provider instead of calling patients before receiving a referral.
eLongest wait (in weeks) for the next available colonoscopy appointment within the last year, with priority given to FIT-positive patients.
fLicensed providers (i.e., medical doctor and registered nurse) attempted contact before removing the patient from the list of active patients needing follow-up.
gRefers to the gastroenterology department leadership receiving and sharing performance reports of colonoscopy completion within 30 days.
hDid not respond to the online survey.
iService area leadership was split between 2 gastroenterology departments.
A
m
erican
C
ollege
ofG
astroenterology
C
lin
ical
an
d
T
ran
slatio
n
al
G
astro
en
tero
lo
g
y
COLON
Fo
llo
w
-u
p
A
fter
P
o
sitive
Fecal
Im
m
u
n
o
ch
e
m
ical
T
ests
7
across service areas, which prevented a rigorous evaluation of the
individual inﬂuences of the multiple strategies implemented.
These factors, and the potential that unmeasured temporal
changes could have inﬂuenced the results, preclude deﬁnitive
assessments of causality. For example, we did not ask about the
practice of maintaining open colonoscopy slots for semiurgent
colonoscopy indications like positive FIT; this approach could
decrease colonoscopy wait times (38). In attempting to capture
the strategies implemented over time across service areas, we
relied on information obtained from gastroenterology de-
partment leaders rather than measurable activities of the staﬀ
involved (e.g., medical assistant/registered nurses). As such, the
ﬁndings could be subject to recall bias, and although if non-
diﬀerential, the resulting misclassiﬁcation would be expected to
bias results toward the null. Our analyses focused on the role of
gastroenterology departments in facilitating follow-up because
this was a KPNC-wide emphasis; however, primary care
departments may have played a greater role in follow-up, which
could have confounded our results. The misclassiﬁcation of ser-
vice areas would be expected to be nondiﬀerential, leading to
a potential bias toward the null. Our observations are from
a single, large health system with an organized screening pro-
gram, which may limit generalizability to smaller programs or
individual practices. However, the impressive improvements in
colonoscopy follow-up over time, combined with high plausi-
bility regarding potential eﬀects of the implemented strategies
described, suggest that these strategies may be useful for con-
sideration by other FIT programs. Finally, we did notmeasure the
proportion of FIT-positive participants for whom follow-up
colonoscopy was inappropriate, either because of a recent normal
colonoscopy, informed refusal, or severe comorbidities, and thus
may have underestimated the proportion of participants re-
ceiving appropriate timely follow-up.
Timely follow-up of positive tests is a critical component of
eﬀectiveness for FIT-based CRC screening programs. This large,
multicenter qualitative and quantitative study of pragmatic
strategies coinciding with improvements in FIT follow-up com-
plements results from small randomized trials and supports goal
setting for colonoscopy completion, electronic tracking of par-
ticipants with positive FITs, organized (including dedicated
personnel) primary care provider–directed evaluation/referral or
direct referral to gastroenterology for colonoscopy, and scaling of
colonoscopy capacity as potential fruitful strategies for improving
timely follow-up of FIT-positive participants. Future intervention
studies in multiple settings are needed to measure the potential
beneﬁcial eﬀects of implementing individual strategies.
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